Female Synthetic Hormone Nafarelin Acetate (synarel) 76932-56-4 for Treating Endometriosis
- Κατασκευαστής: Dewael
- Δοκιμασία προϊόν: 99%+
- Εμφάνιση:White lyophilized powder
- Τόπο καταγωγής: Κίνα
- Πιστοποίηση: SGS,ISO9001, GMP
- Ελάχιστη ποσότητα παραγγελίας: 100ml
- λεπτομέρειες συσκευασίας: Διακριτική τρόπους συσκευασίας για τα τελωνεία Pass Εγγυημένα
- Ωρα παράδοσης: Στα πλαίσια 12 ώρες μετά τη λήψη της πληρωμής σας
- Οροι πληρωμής: Δυτική Ένωση, MoneyGram,Bitcoin,Τραπεζική μεταφορά
- Αποστολή: EMS,DHL,Fedex,UPS,TNT και ούτω καθεξής.
- Πολιτική: Re-Shipping Πολιτική
- δυνατότητα εφοδιασμού: 500-600Λίτρα / μήνα
Female Synthetic Hormone Nafarelin Acetate (synarel) 76932-56-4 for Treating Endometriosis
Nafarelin Acetate (synarel) Καθέκαστα:
Όνομα προϊόντος | Nafarelin Acetate |
CAS ΟΧΙ. | 76932-56-4 |
Συνώνυμα | Nafarelin Acetate |
Category | Pharmaceutical Raw Materials,Active Pharmaceutical Ingredients,Bulk Drugs,Fine Chemicals. |
Καθαρότητα | 99% Nafarelin Acetate |
Εμφάνιση | Nafarelin Acetate powder |
Διάρκεια ζωής | 2 years for Nafarelin Acetate |
Χρήση | Nafarelin Acetate is used in female infertility and endometriosis. |
Αποθήκευση | Nafarelin Acetate should be stored in a well-closed containerat low temperature, keep away from moisture, heat and light. |
Περιγραφή
Its proposed mechanism of action could be the desensitization of pituitary GnRH receptors resulting in a decrease in gonadotropin release, and ovarian hormone serum concentrations much like those achieved in postmenopausal women. Nafarelin is administered by nasal inhalation and contains been generally well tolerated. It is associated with a high incidence of adverse effects but they are rarely severe enough to cause withdrawal from treatment, the ones occurring most frequently–hot flashes, vaginal dryness, and decreased libido–are a result of the hypoestrogenemia induced through the drug. Increased bone turnover is situated women on nafarelin but biochemical parameters resume pretreatment concentrations by six months after termination of treatment. This agent’s invest the therapy of endometriosis will be determined as clinical experience accumulates.
Nafarelin Acetate Application:
Treating endometriosis, including relieving pain and reducing lesions. It is usually used to treat early puberty (central precocious puberty [CPP]) in children of both sexes. It could be used for other difficulties as determined by your doctor.
Nafarelin is really a gonadotropin-releasing hormone (GnRH) agonist. It functions by decreasing creation of certain steroids in your body, which decreases the symptoms of endometriosis or early puberty.
COA
Item | Προσδιορισμός | Result |
Εμφάνιση | White powder | Συμμορφώνεται |
Αναγνώριση | Θετικός | Συμμορφώνεται |
Χημική δοκιμή | 98.0% ελάχ | 98.2% |
Loss on Drying | 6.0%μέγ. | 5.8% |
Περιεκτικότητα σε οξικό άλας(με HPLC) | 10.0%μέγ. | 9.8% |
Peptide Content (N%) | 80.0%ελάχ. | 88.0% |
Amino Acid Composition | ±10% of theoretical | Συμμορφώνεται |
Single Impurity (HPLC) | 1.0%μέγ. | 0.45% |
MS(ESI) | Consistent | Συμμορφώνεται |
Mass Balance | 95.0~105.0% | 98.0% |
———————————————————————————————————————————————————————————————————————————————————————-
Επικοινώνησε τώρα
Κριτικές
Δεν υπάρχουν σχόλια ακόμη.